Evidence map›Paper›PMID 31824446›Full record

ArticleFrontiers in microbiology2019

Sated by a Zero-Calorie Sweetener: Wastewater Bacteria Can Feed on Acesulfame.

Sabine Kleinsteuber, Thore Rohwerder, Ute Lohse, Bettina Seiwert, Thorsten Reemtsma

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Re-evaluation of acesulfame K (E 950) as food additive.EFSA journal. European Food Safety Authority · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. A Review of the Environmental Fate and Effects of Acesulfame-Potassium.Integrated environmental assessment and management · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sabine KleinsteuberDepartment of Environmental Microbiology, Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany.
Thore RohwerderDepartment of Environmental Microbiology, Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany.
Ute LohseDepartment of Environmental Microbiology, Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany.
Bettina SeiwertDepartment of Analytical Chemistry, Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany.
Thorsten ReemtsmaDepartment of Analytical Chemistry, Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany.
Helmholtz Centre for Environmental Research · DELeipzig University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widely used artificial sweetener acesulfame K has long been considered recalcitrant in biological wastewater treatment. Due to its persistence and mobility in the aquatic environment, acesulfame has been used as marker substance for wastewater input in surface water and groundwater. However, recent studies indicated that the potential to remove this xenobiotic compound is emerging in wastewater treatment plants worldwide, leading to decreasing mass loads in receiving waters despite unchanged human consumption patterns. Here we show evidence that acesulfame can be mineralized in a catabolic process and used as sole carbon source by bacterial pure strains isolated from activated sludge and identified as

Indexed as

amidohydrolasebiodegradationbiotransformationmicrobial adaptationmicropollutantsorganic contaminantsulfohydrolasetrace organic compounds

Identifiers

PMID31824446
PMCPMC6879467
OpenAlexW2986033730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.